- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Justin Bachmann on How Cardiology Is Handling Transition to Value-Based Care
Justin Bachmann, MD, MPH, FACC, instructor of Medicine and Health Policy at Vanderbilt University Medical Center, discusses how cardiologists incorporate value-based care into their procedures.
Justin Bachmann, MD, MPH, FACC, instructor of Medicine and Health Policy at Vanderbilt University Medical Center, discusses how cardiologists incorporate value-based care into their procedures.
Transcript
How is cardiology handling the transition to value-based care and what models are a good fit with cardiology care?
I say we have a little bit of a head start. So cardiology has been involved in value-based care for a while now. We started in the '90s with the development with our registries, specifically the National Cardiovascular Data Registry, which was developed by the American College of Cardiology.
So we have registries that focus on specific procedures, for example PCI or percutaneous coronary intervention, this is soften normally for to as a stent. Also things such as implantable cardioverter defibrillators (ICDs). So these registries collect granular information on patients who are going through these procedures. That really prepared us for that transition so it continued to evolve as bundled payments and episodes of care continue to evolve. I think cardiology will be prepared for that.
A number of the proposed bundled payment models, for example focused on acute myocardio infarction or bypass and those, are a little bit in flux in present, but as these models continue to change and evolve and they’ll continue to do so over the coming years. I think cardiologists will engage with those.
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Ways Providers, Payers Can Ensure Biomarker Testing Is Done in Cancer Care
October 18th 2024There is a role for both payers and providers to make small changes that would increase the use of biomarker testing to ensure patients are receiving the appropriate treatment, said Susan Wescott, RPh, MBA, senior director of managed care pharmacy, Mayo Clinic.
Read More
